Xiaodong Ling
Overview
Explore the profile of Xiaodong Ling including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
156
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Peng G, Ling X, Lin Y, Jiang H, Ma M, Yu A, et al.
RSC Adv
. 2023 Oct;
13(44):31036-31046.
PMID: 37881768
Herein, a comprehensive investigation is performed to research the thermal runaway features of large-format power lithium-ion cells under various heating patterns (2 kW electric heating oven and 600 W electric...
12.
Gu M, Chen G, Wang H, Yu A, Ling X, Li J
ACS Omega
. 2023 Jul;
8(26):23840-23850.
PMID: 37426267
Seven deflagration tests of a propane-air mixture were carried out in a 22.5 m large-scale chamber. The effects of initial volume, gas concentration, and initial turbulence intensity on deflagration characteristics...
13.
Ling X, Zhang L, Fang C, Liang H, Zhu J, Ma J
Transl Lung Cancer Res
. 2023 May;
12(4):754-769.
PMID: 37197625
Background: Cuproptosis is a novel mitochondrial respiration-dependent cell death mechanism induced by copper that can kill cancer cells via copper carriers in cancer therapy. However, the clinical significance and prognostic...
14.
Zhu J, Cao K, Zhao M, Ma K, Jiang X, Bai Y, et al.
Mol Med
. 2023 Jan;
29(1):6.
PMID: 36647009
Background: Activated Cdc42-associated kinase 1 (ACK1) is a promising druggable target for cancer, but its inhibitors only showed moderate effects in clinical trials. The study aimed to investigate the underlying...
15.
Wang X, Ling X, Wang C, Zhang J, Yang Y, Jiang H, et al.
Cancer Immunol Immunother
. 2022 Dec;
72(6):1619-1631.
PMID: 36583750
Background: Immune checkpoint inhibitors (ICIs) through programmed cell death 1 blockade improve the survival outcomes of patients with advanced esophageal squamous cell carcinoma (ESCC). Recently, the use of neoadjuvant immunotherapy...
16.
Cao K, Ling X, Jiang X, Ma J, Zhu J
Respir Res
. 2022 Nov;
23(1):306.
PMID: 36357897
Background: Ubiquitin-conjugating enzyme E2 T (UBE2T) is a potential oncogene. However, Pan-cancer analyses of the functional, prognostic and predictive implications of this gene are lacking. Methods: We first analyzed UBE2T...
17.
Ma J, Cao K, Ling X, Zhang P, Zhu J
Cancers (Basel)
. 2022 Jun;
14(12).
PMID: 35740511
It is imperative to advance the understanding of lung cancer biology. The Cancer Genome Atlas (TCGA) dataset was used for bioinformatics analysis. CCK-8 assay, flow cytometry, and western blot were...
18.
Chen F, Ling X, Zhao Y, Fu S
Fish Physiol Biochem
. 2022 Jun;
48(4):911-924.
PMID: 35697912
Scaleless carp (Gymnocypris przewalskii) are well adapted to low oxygen environment, but their specific adaptation mechanism to hypoxic condition remains unclear. The gill is an important respiratory organ that plays...
19.
Zhang L, Liang H, Zhang J, Yang Y, Ling X, Jiang H
Curr Med Chem
. 2022 May;
29(39):6084-6099.
PMID: 35579168
Objective: This research sought to explore the effect and mechanism of long non-coding RNA SNHG16 on esophageal cancer (EC) cell proliferation and self-renewal. Methods: SNHG16 expression was measured in EC9706...
20.
Zhang J, Ling X, Fang C, Ma J
Cell Mol Biol Lett
. 2022 May;
27(1):39.
PMID: 35578166
Background: Esophageal squamous cell carcinoma (ESCC) is correlated with worse clinical prognosis and lacks available targeted therapy. Thus, identification of reliable biomarkers is required for the diagnosis and treatment of...